Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MYL9 |
| Upstream (Parents) |
|---|
| (<<) ACTA2 → MYL9 |
| (<<) AKT3 → MYL9 |
| (<<) CHSY1 → MYL9 |
| (<<) CTGF → MYL9 |
| (<<) ISLR → MYL9 |
| (<<) MXRA8 → MYL9 |
| (<<) SULF1 → MYL9 |
| (<<) VIM → MYL9 |
| Downstream (Children) |
|---|
| MYL9 → ACTC1 (>>) |
| MYL9 → ACTN1 (>>) |
| MYL9 → CRYAB (>>) |
| MYL9 → CYR61 (>>) |
| MYL9 → HOPX (>>) |
| MYL9 → IGFBP7 (>>) |
| MYL9 → ILK (>>) |
| MYL9 → MN1 (>>) |
| MYL9 → MYLK (>>) |
| MYL9 → PGF (>>) |
| MYL9 → PHOX2A (>>) |
| MYL9 → PIP5K1C (>>) |
| MYL9 → PODXL (>>) |
| MYL9 → PTRF (>>) |
| MYL9 → RRAS (>>) |
| MYL9 → SOD3 (>>) |
| MYL9 → THY1 (>>) |
| MYL9 → TIMP3 (>>) |
| MYL9 → TPM4 (>>) |
